GlassScriptPhysician profile
Kim E Schmitt
NPI 1063486546
$2,049.16
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.37 · 2020: $55.29 · 2021: $1,357 · 2022: $306 · 2023: $113 · 2024: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $292.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $1,209.43 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $358.33 | 2021-2024 | Dupixent |
| Optinose US, INC. | $129.73 | 2019-2022 | |
| Stryker Corporation | $108.46 | 2022 | |
| Aerin Medical INC. | $33.61 | 2020 | |
| Polynovo North America LLC | $30.80 | 2024 | Novosorb Btm |
| Phadia US INC. | $29.67 | 2024 | Immunocap |
| Acclarent, INC | $27.98 | 2021 | |
| Integra Lifesciences Corporation | $21.46 | 2023 | Codman Isocool Aht, Microfrance, Integra Duo |
| Alk-Abello, INC | $20.97 | 2019 | |
| Glaxosmithkline, LLC. | $18.77 | 2024 | Nucala |
| Bioventus LLC | $16.92 | 2022 | |
| Lilly USA, LLC | $15.55 | 2021 | |
| Baxter Healthcare | $14.15 | 2021 | |
| Genzyme Corporation | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Schmitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.